CJC-1295/Ipamorelin Blend (10 Vial Box)

CJC-1295 is a synthetic peptide analog that interacts with the growth hormone–releasing hormone (GHRH) receptor, facilitating endogenous stimulation of growth hormone (GH) secretion through receptor-mediated pathways. Its structure is designed to enhance stability and extend half-life compared to native GHRH, making it a subject of interest in pharmacokinetic and endocrine research.

Ipamorelin is classified as a highly selective GH secretagogue and functions as an agonist of the ghrelin/growth hormone secretagogue receptor (GHS-R). Preclinical and clinical investigations have explored its receptor specificity and signaling properties, with research focusing on its role in modulating GH release and associated physiological processes.

Studies examining CJC-1295 in combination with Ipamorelin have reported synergistic activity in stimulating GH secretion under controlled experimental conditions. This combination is frequently utilized in research protocols aimed at understanding peptide interactions within the somatotropic axis.